The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.
FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
The Office of the Assistant Secretary for Health seeks public comments on a proposed threshold for scheduling 7-hydroxymitragynine under the Controlled Substances Act.
FDA withdraws approval of 34 new drug applications across multiple applicants whose manufacturers requested withdrawal due to discontinued marketing.
Centers for Medicare & Medicaid Services launches a matching program with the Department of Veterans Affairs to verify eligibility for insurance affordability programs under the Affordable Care Act.
New York's Administrative Declaration of Disaster dated June 30, 2026, covers severe storms and flooding and may trigger state and federal disaster assistance programs for affected small businesses.
Multiple federal agency forms are undergoing Paperwork Reduction Act review to assess and potentially reduce reporting burdens on small businesses and other respondents.
EPA announces receipt of pesticide residue petitions for various commodities and opens public comment period; petitions filed in 2025 and 2026 are under evaluation for regulatory establishment or modification.
FAA proposes to clarify that federal flightcrew and flight attendant duty and rest regulations preempt all state and local meal and rest break requirements under the Airline Deregulation Act of 1978.
FDA corrects contact information for the Expedited Investigational New Drug Pilot Program docket, which solicits public input on shortening timelines from drug identification to first-in-human clinical trials.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
